IFI44, IFI44L and OAS1 are potential diagnostic biomarkers, though the results for these genes were not as remarkable as those for ANXA1. However, our study mainly describes the variation in ANXA1 in several solid cancers, and the inclusion of more cancer types and application of further experiments for validation are needed. Here, IFI44 is linked to cancer.